bioAffinity Technologies, Inc. (BIAF)
bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is based in San Antonio, Texas.
$27.12M
Ms. Maria Zannes J.D.
11.00
San Antonio, TX
Sep 01, 2022
-2.21
$-0.91
0.34
1.15
-119.41%
-2.41
-0.10
6.14
3.41
1.14
-131.24%
-170.13%
Similar stocks (5)
T2 Biosystems, Inc.
TTOO
Psychemedics Corporation
PMD
Precipio, Inc.
PRPO
Interpace Biosciences, Inc.
IDXG
Intelligent Bio Solutions Inc.
INBS
ETF Exposure (5)
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (5)
T2 Biosystems, Inc.
TTOO
Psychemedics Corporation
PMD
Precipio, Inc.
PRPO
Interpace Biosciences, Inc.
IDXG
Intelligent Bio Solutions Inc.
INBS
ETF Exposure (5)
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%